1. Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy
- Author
-
Jan C. Oosterwijk, Anthony Absalom, Natalia Teixeira, Peter van der Meer, Geertruida H. de Bock, Ingrid E. Fakkert, Stephan J. L. Bakker, Marian J.E. Mourits, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE), Groningen Institute for Organ Transplantation (GIOT), Lifestyle Medicine (LM), Groningen Kidney Center (GKC), Cardiovascular Centre (CVC), Life Course Epidemiology (LCE), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), and Restoring Organ Function by Means of Regenerative Medicine (REGENERATE)
- Subjects
Counseling ,0301 basic medicine ,Cancer Research ,Time Factors ,medicine.medical_treatment ,Menopause, Premature ,030105 genetics & heredity ,0302 clinical medicine ,Epidemiology ,Medicine ,Genetics (clinical) ,Premature Menopause ,METABOLIC SYNDROME ,Ovarian Neoplasms ,BRCA1 Protein ,Obstetrics ,Age Factors ,Middle Aged ,CHEMOTHERAPY ,CARRIERS ,Treatment Outcome ,Cholesterol ,Oncology ,CARDIOVASCULAR-DISEASE ,030220 oncology & carcinogenesis ,Original Article ,Female ,Adult ,medicine.medical_specialty ,Salpingo-oophorectomy ,General Population Cohort ,BREAST ,03 medical and health sciences ,AGE ,Genetics ,Humans ,Genetic Predisposition to Disease ,CORONARY-HEART-DISEASE ,Risk reducing salpingo-oophorectomy ,Germ-Line Mutation ,METAANALYSIS ,BRCA2 Protein ,business.industry ,Anthropometry ,medicine.disease ,BRCA1 ,BRCA2 ,REDUCTION ,Cross-Sectional Studies ,Premenopause ,Dyslipidemia ,DENSITY ,Hormone therapy ,Metabolic syndrome ,business ,Risk Reduction Behavior ,Body mass index - Abstract
This cross-sectional study aimed to investigate the effect of premenopausal risk reducing salpingo-oophorectomy (RRSO) on the cholesterol profile of women at increased ovarian cancer risk and to assess possible effects of age at and time since RRSO. We included 207 women who underwent RRSO before menopausal age (52 years) attending the family cancer clinic of an academic hospital and 828 age-matched women from a general population cohort (PREVEND). Participants filled out a questionnaire on socio-demographic characteristics, lifestyle and medical history, had anthropometric measurements and provided blood samples for assessment of serum levels of total cholesterol, HDL-cholesterol and non-HDL-cholesterol. The correlation between RRSO and cholesterol profile was assessed with logistic regression. Furthermore, subgroup analyses were performed to explore a possible effect of age at and time since RRSO. At a median time of 5.9 years (range 2.3–25.2) after surgery, RRSO was associated with low (
- Published
- 2019